LAT1 is abundant and selectively expressed on both luminal and abluminal membrane sides of the BBB, and it shows higher substrate affinity than that on peripheral tissues [92,93] and is overexpressed in glioblastoma tumor cells [94,95], which makes the design of the LAT1-mediated drug delivery system possible. The gene discussed is LAT; the disease is glioblastoma.